With valuations growing across the stock market and the biopharma sector, it's only natural for value-sensitive investors to ...

Drugmaker Eli Lilly signed an agreement with the U.K. government to support early-stage life sciences businesses in the country. As part of the collaboration, which was announced Monday at the U.K.'s ...

Eli Lilly & Co plans to invest £279 million ($364 million) in a new initiative to support UK biotechs along with a study of ...

Eli Lilly (LLY) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the ...

Lilly’s latest investment comes on the heels of three earlier rounds of manufacturing investment at the LEAP Research and ...

Three Fool.com contributors have identified what they believe are no-brainer growth stocks to buy in October. Here's why they picked Eli Lilly (NYSE: LLY), Novo Nordisk (NYSE: NVO), and Vertex ...

Eli Lilly and Company announced data demonstrating more patients with moderately to severely active Crohn's disease treated with mirikizumab ...

The US regulator has said that compounders can continue to trade in tirzepatide products while it undertakes a review to ...

The activist investment firm Starboard Value has launched a proxy fight again Pfizer, questioning the company’s management ...

A major trial is coming to Greater Manchester to see how a new drug can tackle obesity.

Barely three years since its coronavirus vaccine helped stem the pandemic, Pfizer’s stock has lost 50 percent of its value ...

Britain on Monday asked its antitrust regulator to make growth and investment a priority as the government sought to woo some ...